Notably, IGF2BP3 sustained IGF2 and IGF1R mRNA translation in tumor cells [10] but any involvement of the IGF2BP3/IGF2/IGF1R axis in response to BET inhibitors has not been yet established. The gene discussed is IGF2BP3; the disease is neoplasm.